We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HHS Awards Virginia Firm $354 Million to Manufacture Essential COVID-19 Medicines
HHS Awards Virginia Firm $354 Million to Manufacture Essential COVID-19 Medicines
In a surprise move, HHS has awarded a new Virginia-based company a $354 million contract to produce active pharmaceutical ingredients (APIs) and finished drugs to create a new Strategic Active Pharmaceutical Ingredients Reserve.